| Harmoney Corp Limited (HMY) ORDINARY FULLY PAID |
Financials |
$78 |
Update - Notification of buy-back - HMY
|
23 Mar 2026 7:58AM |
$0.705 |
$0.750 |
risen by
6.38%
|
|
| Suncorp Group Limited (SUN) ORDINARY FULLY PAID |
Financials |
$18,551 |
Update - Notification of buy-back - SUN
|
23 Mar 2026 7:43AM |
$15.810 |
$17.130 |
risen by
8.35%
|
|
| Summerset Group Holdings Limited (SNZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$1,587 |
DRP Strike Price and AUD FX Rate for 2025 Final Dividend
|
23 Mar 2026 7:33AM |
$7.700 |
$6.500 |
fallen by
15.58%
|
|
| Summerset Group Holdings Limited (SNZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$1,587 |
Update - Dividend/Distribution - SNZ
|
23 Mar 2026 7:32AM |
$7.700 |
$6.500 |
fallen by
15.58%
|
|
| Sky Network Television Limited (SKT) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$362 |
Ongoing Disclosure Notice - Philip Bowman
|
23 Mar 2026 7:31AM |
$2.660 |
$2.630 |
fallen by
1.13%
|
|
| Mercury NZ Limited (MCY) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$7,952 |
Mercury launches retail Green Bond offer
|
23 Mar 2026 7:31AM |
$5.420 |
$5.580 |
risen by
2.95%
|
|
| Mercury NZ Limited (MCY) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$7,952 |
Mercury Cleansing Notice
|
23 Mar 2026 7:31AM |
$5.420 |
$5.580 |
risen by
2.95%
|
|
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$205 |
Synlait HY26 result and recovery roadmap - Result template
|
23 Mar 2026 7:31AM |
$0.410 |
$0.340 |
fallen by
17.07%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations remained static at NZD 777,581,000.
- Total revenue increased by 4% to NZD 949,029,000.
- Net profit from continuing operations decreased by 466% to a loss of NZD 71,869,000.
- Total net profit showed a loss of NZD 80,628,000, a decline of 1777%.
- No dividends are proposed for this period.
- Net tangible assets per quoted equity security decreased to NZD 0.98.
- The results include a Chair & CEO Review, Financial Statements, and Investor Presentation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$205 |
Synlait HY26 result and recovery roadmap - Letter
|
23 Mar 2026 7:30AM |
$0.410 |
$0.340 |
fallen by
17.07%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Synlait Milk Limited is in the process of selling its North Island assets to Abbott for approximately NZ$307 million.
- The company released its half-year results for the six months ended 31 January 2026, highlighting ongoing challenges.
- Synlait has developed a 'Stabilise, Simplify and Scale' recovery roadmap to improve financial performance.
- The sale of North Island assets is expected to significantly improve Synlait's balance sheet.
- Synlait is focusing on operational stability and maximizing its South Island assets for future success.
- The company acknowledges the disappointment in the current financial results but remains optimistic about long-term recovery.
- Synlait's leadership expresses determination to over-deliver in the next 12 to 24 months.
- The half-year results and recovery roadmap were shared with shareholders on 23 March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$205 |
Synlait HY26 result & recovery roadmap - Presentation
|
23 Mar 2026 7:30AM |
$0.410 |
$0.340 |
fallen by
17.07%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Synlait reported a total Group EBITDA of negative $34.7 million.
- Net profit after tax was a negative $80.6 million for HY26.
- Three core issues: manufacturing adjustments, lower ingredients returns, deferred tax assets.
- Roadmap includes stabilizing operations, simplifying processes, scaling growth.
- Focus on customer satisfaction, financial resilience, operational stability.
- Plan to sell North Island operations to reduce net debt.
- Emphasis on transforming business through strategic market expansion.
- Development of new products and enhancing existing offerings.
- Expanding Synlait’s customer base domestically and internationally.
- North Island sale expected to complete by 1 April 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$205 |
Synlait HY26 result - Financial Statements
|
23 Mar 2026 7:30AM |
$0.410 |
$0.340 |
fallen by
17.07%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax of $71.9 million for the period ended 31 January 2026.
- Revenue decreased to $778 million from $779 million in the prior period.
- Significant expenditures in employee costs and energy.
- Ongoing sale of North Island operations, completion expected by April 2026.
- Total assets reported at $1.78 billion, liabilities at $1.07 billion.
- Directors expect future profitability improvement and operational gains.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$205 |
Synlait HY26 result & recovery roadmap - CEO & Chair Review
|
23 Mar 2026 7:30AM |
$0.410 |
$0.340 |
fallen by
17.07%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Synlait faced disappointing financial results for HY26, attributed to multiple challenges and a lack of optionality.
- The company is implementing a recovery roadmap titled 'Stabilise, Simplify, Scale' to reposition for future success.
- Key strategic actions include the sale of North Island assets, which is expected to strengthen the balance sheet.
- A new leadership team has been appointed to drive operational and cultural transformation.
- Synlait continues to manage relationships with key customers such as The a2 Milk Company and Abbott.
- The company is focused on rebuilding customer inventory and improving manufacturing plans.
- Financial resilience is a key area of focus, with cash flow management and asset sales as central strategies.
- Synlait is not providing FY26 financial guidance, reflecting the uncertainty during the recovery phase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synlait Milk Limited (SM1) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$205 |
Synlait HY26 result and recovery roadmap - announcement
|
23 Mar 2026 7:30AM |
$0.410 |
$0.340 |
fallen by
17.07%
|
|
SM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported EBITDA loss of $34.7 million.
- Net loss after tax of $80.6 million.
- Revenue increased by $32.3 million to $949 million.
- Introduced 'Stabilise, Simplify and Scale' recovery roadmap.
- Challenges due to manufacturing adjustments and lower ingredient returns.
- Forecast milk price for 2025/26 season is $9.50 per kg MS.
- Focus on selling North Island assets to improve financial health.
- Manufacturing challenges led to excess milk management issues.
- CEO Richard Wyeth emphasizes future potential beyond current results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elsight Limited (ELS) ORDINARY FULLY PAID |
Information Technology |
$1,519 |
Change in substantial holding
|
20 Mar 2026 8:30PM |
$5.900 |
$6.890 |
risen by
16.78%
|
|
| Kinatico Ltd (KYP) ORDINARY FULLY PAID |
Information Technology |
$66 |
Appendix 3Y - G Chmiel
|
20 Mar 2026 8:30PM |
$0.135 |
$0.150 |
risen by
11.11%
|
|
| WA Kaolin Limited (WAK) ORDINARY FULLY PAID |
Materials |
$17 |
ASX Voluntary Suspension Extension
|
20 Mar 2026 7:57PM |
$0.025 |
$0.025 |
fallen by
0%
|
|
| Magnetite Mines Limited (MGT) ORDINARY FULLY PAID |
Materials |
$6 |
Correction to ASX Announcement
|
20 Mar 2026 7:53PM |
$0.040 |
$0.027 |
fallen by
32.50%
|
|
| Sarytogan Graphite Limited (SGA) ORDINARY FULLY PAID |
Materials |
$23 |
Change in substantial holding
|
20 Mar 2026 7:45PM |
$0.090 |
$0.086 |
fallen by
4.44%
|
|
| Zuleika Gold Limited (ZAG) ORDINARY FULLY PAID |
Materials |
$27 |
Change of Director's Interest Notice
|
20 Mar 2026 7:39PM |
$0.036 |
$0.029 |
fallen by
19.44%
|
|
| Zuleika Gold Limited (ZAG) ORDINARY FULLY PAID |
Materials |
$27 |
Change in substantial holding
|
20 Mar 2026 7:38PM |
$0.036 |
$0.029 |
fallen by
19.44%
|
|
| West African Resources Limited (WAF) ORDINARY FULLY PAID |
Materials |
$3,372 |
Change of Director's Interest Notice X 4
|
20 Mar 2026 7:32PM |
$2.930 |
$2.950 |
risen by
0.68%
|
|
| West African Resources Limited (WAF) ORDINARY FULLY PAID |
Materials |
$3,372 |
Application for quotation of securities - WAF
|
20 Mar 2026 7:25PM |
$2.930 |
$2.950 |
risen by
0.68%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$15 |
Change in substantial holding from SOL
|
20 Mar 2026 7:21PM |
$0.485 |
$0.500 |
risen by
3.09%
|
|
| Washington H. Soul Pattinson and Co. Limited (SOL) ORDINARY FULLY PAID |
Financials |
$16,139 |
Change in substantial holding for OSL
|
20 Mar 2026 7:21PM |
$38.500 |
$42.480 |
risen by
10.34%
|
|
| Black Cat Syndicate Limited (BC8) ORDINARY FULLY PAID |
Materials |
$802 |
Notification of Release of Securities from Voluntary Escrow
|
20 Mar 2026 7:15PM |
$1.055 |
$1.100 |
risen by
4.27%
|
|
Call 1300 880 160
Start a chat
Schedule a call
